293 related articles for article (PubMed ID: 26820525)
1. A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer.
Yang F; Liu YH; Dong SY; Ma RM; Bhandari A; Zhang XH; Wang OC
Biochem Biophys Res Commun; 2016 Feb; 470(3):479-483. PubMed ID: 26820525
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA FGF14-AS2 represses proliferation, migration, invasion, and induces apoptosis in breast cancer by sponging miR-205-5p.
Yang Y; Xun N; Wu JG
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6971-6982. PubMed ID: 31486497
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Long Non-Coding RNA FGF14-AS2 Inhibits Colorectal Cancer Proliferation Via the RERG/Ras/ERK Signaling by Sponging microRNA-1288-3p.
Hou R; Liu Y; Su Y; Shu Z
Pathol Oncol Res; 2020 Oct; 26(4):2659-2667. PubMed ID: 32654025
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA FGF14-AS2 inhibits breast cancer metastasis by regulating the miR-370-3p/FGF14 axis.
Jin Y; Zhang M; Duan R; Yang J; Yang Y; Wang J; Jiang C; Yao B; Li L; Yuan H; Zha X; Ma C
Cell Death Discov; 2020; 6():103. PubMed ID: 33083023
[TBL] [Abstract][Full Text] [Related]
5. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
[TBL] [Abstract][Full Text] [Related]
6. The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.
Xu S; Wang P; You Z; Meng H; Mu G; Bai X; Zhang G; Zhang J; Pang D
Oncotarget; 2016 Apr; 7(15):20704-17. PubMed ID: 26980733
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
Zhang XF; Liu T; Li Y; Li S
Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701
[TBL] [Abstract][Full Text] [Related]
8. YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation.
Zhang M; Wang J; Jin Y; Zheng Q; Xing M; Tang Y; Ma Y; Li L; Yao B; Wu H; Ma C
Br J Cancer; 2022 Dec; 127(12):2141-2153. PubMed ID: 36216883
[TBL] [Abstract][Full Text] [Related]
9. Landscape of tumor suppressor long noncoding RNAs in breast cancer.
Pang B; Wang Q; Ning S; Wu J; Zhang X; Chen Y; Xu S
J Exp Clin Cancer Res; 2019 Feb; 38(1):79. PubMed ID: 30764831
[TBL] [Abstract][Full Text] [Related]
10. Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer.
Liu XM; Yang B; Han J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8749-8754. PubMed ID: 30575915
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis.
Yang YX; Wei L; Zhang YJ; Hayano T; Piñeiro Pereda MDP; Nakaoka H; Li Q; Barragán Mallofret I; Lu YZ; Tamagnone L; Inoue I; Li X; Luo JY; Zheng K; You H
Clin Exp Metastasis; 2018 Mar; 35(3):109-121. PubMed ID: 29948648
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FGF14-AS2 represses growth of prostate carcinoma cells via modulating miR-96-5p/AJAP1 axis.
Li R; Chen Y; Wu J; Cui X; Zheng S; Yan H; Wu Y; Wang F
J Clin Lab Anal; 2021 Nov; 35(11):e24012. PubMed ID: 34655124
[TBL] [Abstract][Full Text] [Related]
13. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
[TBL] [Abstract][Full Text] [Related]
14. MLF1IP is correlated with progression and prognosis in luminal breast cancer.
Huang DP; Luo RC
Biochem Biophys Res Commun; 2016 Sep; 477(4):923-926. PubMed ID: 27378428
[TBL] [Abstract][Full Text] [Related]
15. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge.
Fang Y; Wang J; Wu F; Song Y; Zhao S; Zhang Q
Oncotarget; 2017 Jul; 8(28):46090-46103. PubMed ID: 28545023
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer.
Wang J; Su Z; Lu S; Fu W; Liu Z; Jiang X; Tai S
Clin Chim Acta; 2018 Oct; 485():229-233. PubMed ID: 29981289
[TBL] [Abstract][Full Text] [Related]
20. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
